Literature DB >> 17001463

Familial neuroendocrine tumor syndromes: from genetics to clinical practice.

Akihiro Sakurai1, Miyuki Katai, Kiyoshi Hashizume, Yoshimitsu Fukushima.   

Abstract

Thanks to recent developments in molecular biology and cancer genetics, genetic testing has become widely available and useful in several kinds of familial tumor syndrome. However, the impact of genetic testing on medical management is not always straightforward. Clinicians have to consider the psychological impact and ethical complexities of communicating hereditary cancer risk information to families. This review notes some points on genetic counseling before and after genetic testing for familial neuroendocrine tumor syndromes.

Entities:  

Mesh：

Year:  2006        PMID： 17001463     DOI： 10.1007/s11102-006-0268-z

Source DB:  PubMed          Journal:  Pituitary        ISSN： 1386-341X            Impact factor:   4.107


  12 in total

1.  Detection of germline deletions using real-time quantitative polymerase chain reaction in Japanese patients with von Hippel-Lindau disease.

Authors:  Keiko Hattori; Jun-ichi Teranishi; Catherine Stolle; Minoru Yoshida; Kei-ichi Kondo; Takeshi Kishida; Hiroshi Kanno; Masaya Baba; Yoshinobu Kubota; Masahiro Yao
Journal:  Cancer Sci       Date:  2006-05       Impact factor: 6.716

2.  A new definition of Genetic Counseling: National Society of Genetic Counselors' Task Force report.

Authors:  Robert Resta; Barbara Bowles Biesecker; Robin L Bennett; Sandra Blum; Susan Estabrooks Hahn; Michelle N Strecker; Janet L Williams
Journal:  J Genet Couns       Date:  2006-04       Impact factor: 2.537

3.  Impact of genetic counseling and DNA testing on individuals with colorectal cancer with a positive family history: a population-based study.

Authors:  Starlene Loader; Cleveland Shields; Peter T Rowley
Journal:  Genet Test       Date:  2005

Review 4.  Guidelines for diagnosis and therapy of MEN type 1 and type 2.

Authors:  M L Brandi; R F Gagel; A Angeli; J P Bilezikian; P Beck-Peccoz; C Bordi; B Conte-Devolx; A Falchetti; R G Gheri; A Libroia; C J Lips; G Lombardi; M Mannelli; F Pacini; B A Ponder; F Raue; B Skogseid; G Tamburrano; R V Thakker; N W Thompson; P Tomassetti; F Tonelli; S A Wells; S J Marx
Journal:  J Clin Endocrinol Metab       Date:  2001-12       Impact factor: 5.958

5.  Surgical treatment of hyperparathyroidism in patients with multiple endocrine neoplasia type 1.

Authors:  Laura A Lambert; Suzanne E Shapiro; Jeffrey E Lee; Nancy D Perrier; Mylene Truong; Michael J Wallace; Ana O Hoff; Robert F Gagel; Douglas B Evans
Journal:  Arch Surg       Date:  2005-04

Review 6.  Parathyroid surgery in familial hyperparathyroid disorders.

Authors:  T Carling; R Udelsman
Journal:  J Intern Med       Date:  2005-01       Impact factor: 8.989

Review 7.  Counselling in multiple endocrine neoplasia syndromes: from individual experience to general guidelines.

Authors:  C J Lips; J W Höppener; B P Van Nesselrooij; R B Van der Luijt
Journal:  J Intern Med       Date:  2005-01       Impact factor: 8.989

8.  Psychosocial consequences of DNA analysis for MEN type 2.

Authors:  F J Grosfeld; C J Lips; H F Ten Kroode; F A Beemer; H G Van Spijker; G J Brouwers-Smalbraak
Journal:  Oncology (Williston Park)       Date:  1996-02       Impact factor: 2.990

9.  The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing.

Authors:  S Wiggins; P Whyte; M Huggins; S Adam; J Theilmann; M Bloch; S B Sheps; M T Schechter; M R Hayden
Journal:  N Engl J Med       Date:  1992-11-12       Impact factor: 91.245

10.  Early treatment of hereditary medullary thyroid carcinoma after attribution of multiple endocrine neoplasia type 2 gene carrier status by screening for ret gene mutations.

Authors:  F Pacini; C Romei; P Miccoli; R Elisei; E Molinaro; F Mancusi; P Iacconi; F Basolo; E Martino; A Pinchera
Journal:  Surgery       Date:  1995-12       Impact factor: 3.982
View more
  2 in total

1.  Cognitive behavioural therapy for depression in multiple endocrine neoplasia type IIB: a 1-year follow-up.

Authors:  Jessica Mejía-Castrejón; Edgar Landa-Ramírez
Journal:  BMJ Case Rep       Date:  2014-06-04

2.  A case of type 1 multiple endocrine neoplasia with esophageal stricture successfully treated with endoscopic balloon dilation and local steroid injection combined with surgical resection of gastrinomas.

Authors:  Hiroyuki Matsubayashi; Noboru Kawata; Naomi Kakushima; Masaki Tanaka; Kohei Takizawa; Yoshimi Kiyozumi; Yasue Horiuchi; Keiko Sasaki; Teiichi Sugiura; Katsuhiko Uesaka; Hiroyuki Ono
Journal:  BMC Gastroenterol       Date:  2017-03-07       Impact factor: 3.067
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.